No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * |
DrugBank |
Disease ID * [Number of diseases] |
1 | Acute myeloid leukemia 4 genes, 3 drugs (DrugBank), 41 diseases shown |
[1] KIT |
D10229 |
Masitinib |
[6] 2, 5, 6, 13, 46, 96 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[2] PML, RARA |
D00094 |
Tretinoin |
[5] 2, 63, 75, 94, 231 |
2 | Adherens junction 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
3 | Adipocytokine signaling pathway 2 genes, 2 drugs (DrugBank), 46 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
4 | Adrenergic signaling in cardiomyocytes 5 genes, 4 drugs (DrugBank), 8 diseases shown |
[3] ADRA1A, ADRA1B, ADRA1D |
D00454 |
Olanzapine |
[2] 2, 8 |
D06623 |
[1] KCNQ1 |
D09569 |
Ezogabine |
[2] 2, 144 |
[1] SCN5A |
D00639 |
Mexiletine |
[5] 1, 2, 10, 113, 114 |
D08215 |
D00642 |
Quinidine |
[3] 2, 8, 13 |
D00643 |
D02272 |
D08458 |
5 | African trypanosomiasis 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
6 | AGE-RAGE signaling pathway in diabetic complications 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
7 | Alanine, aspartate and glutamate metabolism 4 genes, 1 drug (DrugBank), 14 diseases shown |
[4] ABAT, ALDH5A1, GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
8 | Alcoholism 10 genes, 12 drugs (DrugBank), 21 diseases shown |
[1] ADORA2A |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
D01453 |
[1] DDC |
D00558 |
Carbidopa |
[8] 2, 4, 6, 13, 17, 90, 164, 201 |
[2] DRD1, DRD2 |
D09886 |
Dexpramipexole |
[1] 2 |
D00059 |
Levodopa |
[7] 2, 4, 6, 17, 90, 164, 201 |
[1] DRD2 |
D00454 |
Olanzapine |
[2] 2, 8 |
D06623 |
D00560 |
Pimozide |
[1] 2 |
D00559 |
Pramipexole |
[2] 2, 6 |
D05575 |
[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
D07283 |
Esketamine |
[3] 2, 4, 70 |
D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
D08174 |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
[1] MAOB |
D02562 |
Rasagiline |
[4] 2, 5, 6, 17 |
D08469 |
D10829 |
9 | Aldosterone synthesis and secretion 5 genes, 3 drugs (DrugBank), 27 diseases shown |
[3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
[1] MC2R |
D00146 |
Corticotropin |
[12] 2, 13, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 |
[1] PDE2A |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
D01453 |
10 | Allograft rejection 21 genes, 2 drugs (DrugBank), 20 diseases shown |
[20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
11 | Alzheimer disease 12 genes, 7 drugs (DrugBank), 52 diseases shown |
[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
D07283 |
Esketamine |
[3] 2, 4, 70 |
D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
D08174 |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] RTN4 |
D10331 |
Ozanezumab |
[1] 2 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
12 | Amoebiasis 3 genes, 2 drugs (DrugBank), 31 diseases shown |
[2] IL1R1, IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
13 | Amphetamine addiction 17 genes, 11 drugs (DrugBank), 45 diseases shown |
[1] DDC |
D00558 |
Carbidopa |
[8] 2, 4, 6, 13, 17, 90, 164, 201 |
[1] DRD1 |
D09886 |
Dexpramipexole |
[1] 2 |
D00059 |
Levodopa |
[7] 2, 4, 6, 17, 90, 164, 201 |
[4] GRIA1, GRIA2, GRIA3, GRIA4 |
D08964 |
Perampanel |
[3] 2, 6, 144 |
D02696 |
Talampanel |
[2] 2, 6 |
[9] GRIA1, GRIA2, GRIA3, GRIA4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
D07283 |
Esketamine |
[3] 2, 4, 70 |
D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
D08174 |
[1] MAOB |
D02562 |
Rasagiline |
[4] 2, 5, 6, 17 |
D08469 |
D10829 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
14 | AMPK signaling pathway 3 genes, 3 drugs (DrugBank), 45 diseases shown |
[1] ADRA1A |
D00454 |
Olanzapine |
[2] 2, 8 |
D06623 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
15 | Amyotrophic lateral sclerosis (ALS) 13 genes, 8 drugs (DrugBank), 53 diseases shown |
[2] GRIA1, GRIA2 |
D08964 |
Perampanel |
[3] 2, 6, 144 |
D02696 |
Talampanel |
[2] 2, 6 |
[7] GRIA1, GRIA2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
D07283 |
Esketamine |
[3] 2, 4, 70 |
D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
D08174 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
16 | Antifolate resistance 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
17 | Antigen processing and presentation 21 genes, 2 drugs (DrugBank), 20 diseases shown |
[20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
18 | Apelin signaling pathway 2 genes, 4 drugs (DrugBank), 39 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] PDE3B |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
D01453 |
D01385 |
Ibudilast |
[2] 2, 13 |
D04720 |
Levosimendan |
[1] 2 |
19 | Apoptosis 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
20 | Arachidonic acid metabolism 1 gene, 1 drug (DrugBank), 9 diseases shown |
[1] PTGS2 |
D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
21 | Arginine and proline metabolism 1 gene, 1 drug (DrugBank), 4 diseases shown |
[1] MAOB |
D02562 |
Rasagiline |
[4] 2, 5, 6, 17 |
D08469 |
D10829 |
22 | Asthma 15 genes, 2 drugs (DrugBank), 20 diseases shown |
[14] HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
23 | Autoimmune thyroid disease 20 genes, 1 drug (DrugBank), 4 diseases shown |
[20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
24 | Autophagy - animal 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
25 | Autophagy - other 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
26 | Axon guidance 9 genes, 3 drugs (DrugBank), 31 diseases shown |
[2] ABL1, SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[2] ROCK1, ROCK2 |
D07941 |
Fasudil |
[1] 2 |
27 | B cell receptor signaling pathway 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
28 | Bacterial invasion of epithelial cells 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
29 | beta-Alanine metabolism 3 genes, 1 drug (DrugBank), 14 diseases shown |
[3] ABAT, GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
30 | Bladder cancer 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
31 | Breast cancer 4 genes, 3 drugs (DrugBank), 40 diseases shown |
[2] ESR1, ESR2 |
D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
D08559 |
[1] KIT |
D10229 |
Masitinib |
[6] 2, 5, 6, 13, 46, 96 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
32 | Butanoate metabolism 4 genes, 1 drug (DrugBank), 14 diseases shown |
[4] ABAT, ALDH5A1, GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
33 | C-type lectin receptor signaling pathway 8 genes, 4 drugs (DrugBank), 46 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] PTGS2 |
D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
34 | Caffeine metabolism 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] XDH |
D01206 |
Febuxostat |
[3] 2, 6, 13 |
35 | Calcium signaling pathway 31 genes, 14 drugs (DrugBank), 51 diseases shown |
[2] ADORA2A, PDE1B |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
D01453 |
[8] ADRA1A, ADRA1B, ADRA1D, HRH1, HTR2A, HTR2B, HTR2C, HTR6 |
D00454 |
Olanzapine |
[2] 2, 8 |
D06623 |
[3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
[4] CHRM1, CHRM2, CHRM3, CHRM5 |
D00138 |
Scopolamine |
[1] 2 |
[1] CYSLTR1 |
D01385 |
Ibudilast |
[2] 2, 13 |
[2] DRD1, DRD5 |
D09886 |
Dexpramipexole |
[1] 2 |
D00059 |
Levodopa |
[7] 2, 4, 6, 17, 90, 164, 201 |
[4] GRIN1, GRIN2A, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
D07283 |
Esketamine |
[3] 2, 4, 70 |
D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
D08174 |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
[1] HRH2 |
D00295 |
Cimetidine |
[1] 2 |
D03503 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] TNNC2 |
D11363 |
Reldesemtiv |
[2] 2, 3 |
36 | cAMP signaling pathway 28 genes, 18 drugs (DrugBank), 32 diseases shown |
[8] ADORA1, ADORA2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
D01453 |
[2] CHRM1, CHRM2 |
D00138 |
Scopolamine |
[1] 2 |
[3] DRD1, DRD2, DRD5 |
D09886 |
Dexpramipexole |
[1] 2 |
D00059 |
Levodopa |
[7] 2, 4, 6, 17, 90, 164, 201 |
[1] DRD2 |
D00560 |
Pimozide |
[1] 2 |
D00559 |
Pramipexole |
[2] 2, 6 |
D05575 |
[2] DRD2, HTR6 |
D00454 |
Olanzapine |
[2] 2, 8 |
D06623 |
[2] GABBR1, GABBR2 |
D00241 |
Baclofen |
[5] 2, 10, 13, 18, 149 |
[4] GRIA1, GRIA2, GRIA3, GRIA4 |
D08964 |
Perampanel |
[3] 2, 6, 144 |
D02696 |
Talampanel |
[2] 2, 6 |
[9] GRIA1, GRIA2, GRIA3, GRIA4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
D07283 |
Esketamine |
[3] 2, 4, 70 |
D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
D08174 |
[1] MC2R |
D00146 |
Corticotropin |
[12] 2, 13, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 |
[2] PDE3A, PDE3B |
D04720 |
Levosimendan |
[1] 2 |
[6] PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D |
D01385 |
Ibudilast |
[2] 2, 13 |
[2] ROCK1, ROCK2 |
D07941 |
Fasudil |
[1] 2 |
37 | Cell adhesion molecules (CAMs) 20 genes, 1 drug (DrugBank), 4 diseases shown |
[20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
38 | Cell cycle 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] ABL1 |
D03252 |
Bosutinib |
[2] 2, 67 |
39 | Cellular senescence 12 genes, 3 drugs (DrugBank), 50 diseases shown |
[6] HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
40 | Central carbon metabolism in cancer 2 genes, 2 drugs (DrugBank), 38 diseases shown |
[1] KIT |
D10229 |
Masitinib |
[6] 2, 5, 6, 13, 46, 96 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
41 | cGMP-PKG signaling pathway 18 genes, 8 drugs (DrugBank), 40 diseases shown |
[5] ADORA1, PDE2A, PDE3A, PDE3B, PDE5A |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
D01453 |
[3] ADRA1A, ADRA1B, ADRA1D |
D00454 |
Olanzapine |
[2] 2, 8 |
D06623 |
[3] ADRA2A, ADRA2B, ADRA2C |
D00514 |
Dexmedetomidine |
[11] 2, 4, 6, 21, 34, 70, 113, 212, 215, 226, 280 |
D01205 |
D04375 |
Guanabenz |
[2] 2, 13 |
[2] PDE3A, PDE3B |
D01385 |
Ibudilast |
[2] 2, 13 |
D04720 |
Levosimendan |
[1] 2 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[2] ROCK1, ROCK2 |
D07941 |
Fasudil |
[1] 2 |
42 | Chagas disease (American trypanosomiasis) 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
43 | Chemical carcinogenesis 1 gene, 1 drug (DrugBank), 9 diseases shown |
[1] PTGS2 |
D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
44 | Chemokine signaling pathway 3 genes, 2 drugs (DrugBank), 2 diseases shown |
[2] ROCK1, ROCK2 |
D07941 |
Fasudil |
[1] 2 |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
45 | Choline metabolism in cancer 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
46 | Cholinergic synapse 10 genes, 2 drugs (DrugBank), 2 diseases shown |
[5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 |
D00138 |
Scopolamine |
[1] 2 |
[5] KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5 |
D09569 |
Ezogabine |
[2] 2, 144 |
47 | Chronic myeloid leukemia 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] ABL1 |
D03252 |
Bosutinib |
[2] 2, 67 |
48 | Circadian entrainment 12 genes, 7 drugs (DrugBank), 29 diseases shown |
[3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
[4] GRIA1, GRIA2, GRIA3, GRIA4 |
D08964 |
Perampanel |
[3] 2, 6, 144 |
D02696 |
Talampanel |
[2] 2, 6 |
[9] GRIA1, GRIA2, GRIA3, GRIA4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
D07283 |
Esketamine |
[3] 2, 4, 70 |
D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
D08174 |
49 | Cocaine addiction 10 genes, 13 drugs (DrugBank), 22 diseases shown |
[1] DDC |
D00558 |
Carbidopa |
[8] 2, 4, 6, 13, 17, 90, 164, 201 |
[2] DRD1, DRD2 |
D09886 |
Dexpramipexole |
[1] 2 |
D00059 |
Levodopa |
[7] 2, 4, 6, 17, 90, 164, 201 |
[1] DRD2 |
D00454 |
Olanzapine |
[2] 2, 8 |
D06623 |
D00560 |
Pimozide |
[1] 2 |
D00559 |
Pramipexole |
[2] 2, 6 |
D05575 |
[1] GRIA2 |
D08964 |
Perampanel |
[3] 2, 6, 144 |
D02696 |
Talampanel |
[2] 2, 6 |
[6] GRIA2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
D07283 |
Esketamine |
[3] 2, 4, 70 |
D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
D08174 |
[1] MAOB |
D02562 |
Rasagiline |
[4] 2, 5, 6, 17 |
D08469 |
D10829 |
50 | Collecting duct acid secretion 2 genes, 1 drug (DrugBank), 2 diseases shown |
[2] ATP4A, ATP4B |
D00724 |
Rabeprazole |
[2] 2, 51 |
D08463 |
51 | Colorectal cancer 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
52 | Cortisol synthesis and secretion 4 genes, 2 drugs (DrugBank), 24 diseases shown |
[3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
[1] MC2R |
D00146 |
Corticotropin |
[12] 2, 13, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 |
53 | Cushing syndrome 4 genes, 2 drugs (DrugBank), 24 diseases shown |
[3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
[1] MC2R |
D00146 |
Corticotropin |
[12] 2, 13, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 |
54 | Cytokine-cytokine receptor interaction 10 genes, 9 drugs (DrugBank), 69 diseases shown |
[1] CSF3R |
D03235 |
Filgrastim |
[28] 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
D03247 |
Lenograstim |
[3] 2, 57, 65 |
[1] EPOR |
D03231 |
Erythropoietin |
[9] 2, 6, 13, 22, 46, 47, 70, 95, 96 |
[1] GHR |
D02691 |
Somatotropin |
[18] 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
[2] IL1R1, IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
[1] IL2RA |
D03058 |
Basiliximab |
[7] 2, 50, 65, 66, 97, 222, 228 |
[3] IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
[4] 2, 49, 65, 97 |
[1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
55 | Dilated cardiomyopathy (DCM) 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
56 | Dopaminergic synapse 17 genes, 16 drugs (DrugBank), 48 diseases shown |
[1] DDC |
D00558 |
Carbidopa |
[8] 2, 4, 6, 13, 17, 90, 164, 201 |
[5] DRD1, DRD2, DRD3, DRD4, DRD5 |
D09886 |
Dexpramipexole |
[1] 2 |
D00059 |
Levodopa |
[7] 2, 4, 6, 17, 90, 164, 201 |
[2] DRD2, DRD3 |
D00560 |
Pimozide |
[1] 2 |
[3] DRD2, DRD3, DRD4 |
D00454 |
Olanzapine |
[2] 2, 8 |
D06623 |
D00559 |
Pramipexole |
[2] 2, 6 |
D05575 |
[4] GRIA1, GRIA2, GRIA3, GRIA4 |
D08964 |
Perampanel |
[3] 2, 6, 144 |
D02696 |
Talampanel |
[2] 2, 6 |
[6] GRIA1, GRIA2, GRIA3, GRIA4, GRIN2A, GRIN2B |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
[2] GRIN2A, GRIN2B |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
D07283 |
Esketamine |
[3] 2, 4, 70 |
D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
D08174 |
[1] MAOB |
D02562 |
Rasagiline |
[4] 2, 5, 6, 17 |
D08469 |
D10829 |
[3] PPP3CA, PPP3CB, PPP3CC |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] SCN1A |
D00639 |
Mexiletine |
[5] 1, 2, 10, 113, 114 |
D08215 |
D00642 |
Quinidine |
[3] 2, 8, 13 |
D00643 |
D02272 |
D08458 |
57 | Drug metabolism - cytochrome P450 1 gene, 1 drug (DrugBank), 4 diseases shown |
[1] MAOB |
D02562 |
Rasagiline |
[4] 2, 5, 6, 17 |
D08469 |
D10829 |
58 | Drug metabolism - other enzymes 3 genes, 3 drugs (DrugBank), 35 diseases shown |
[2] IMPDH1, IMPDH2 |
D00752 |
Mycophenolate mofetil |
[32] 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
D05094 |
D05095 |
D05096 |
Mycophenolic acid |
[34] 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
[1] XDH |
D01206 |
Febuxostat |
[3] 2, 6, 13 |
59 | ECM-receptor interaction 1 gene, 1 drug (DrugBank), 4 diseases shown |
[1] SV2A |
D00709 |
Levetiracetam |
[4] 2, 4, 6, 13 |
60 | EGFR tyrosine kinase inhibitor resistance 3 genes, 3 drugs (DrugBank), 46 diseases shown |
[1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
61 | Endocrine and other factor-regulated calcium reabsorption 1 gene, 1 drug (DrugBank), 4 diseases shown |
[1] ESR1 |
D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
D08559 |
62 | Endocrine resistance 4 genes, 3 drugs (DrugBank), 38 diseases shown |
[2] ESR1, ESR2 |
D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
D08559 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
63 | Endocytosis 11 genes, 5 drugs (DrugBank), 16 diseases shown |
[6] HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
[1] IL2RA |
D03058 |
Basiliximab |
[7] 2, 50, 65, 66, 97, 222, 228 |
[3] IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
[4] 2, 49, 65, 97 |
[1] PML |
D00094 |
Tretinoin |
[5] 2, 63, 75, 94, 231 |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
64 | Epithelial cell signaling in Helicobacter pylori infection 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
65 | Epstein-Barr virus infection 21 genes, 2 drugs (DrugBank), 20 diseases shown |
[20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
66 | ErbB signaling pathway 3 genes, 2 drugs (DrugBank), 36 diseases shown |
[2] ABL1, SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
67 | Estrogen signaling pathway 6 genes, 4 drugs (DrugBank), 13 diseases shown |
[2] ESR1, ESR2 |
D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
D08559 |
[2] GABBR1, GABBR2 |
D00241 |
Baclofen |
[5] 2, 10, 13, 18, 149 |
[1] RARA |
D00094 |
Tretinoin |
[5] 2, 63, 75, 94, 231 |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
68 | Fc epsilon RI signaling pathway 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
69 | Fluid shear stress and atherosclerosis 4 genes, 3 drugs (DrugBank), 32 diseases shown |
[2] IL1R1, IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
70 | Focal adhesion 3 genes, 2 drugs (DrugBank), 2 diseases shown |
[2] ROCK1, ROCK2 |
D07941 |
Fasudil |
[1] 2 |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
71 | FoxO signaling pathway 1 gene, 1 drug (DrugBank), 4 diseases shown |
[1] S1PR1 |
D10001 |
Fingolimod |
[4] 2, 13, 14, 156 |
72 | GABAergic synapse 22 genes, 4 drugs (DrugBank), 26 diseases shown |
[3] ABAT, GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
[2] GABBR1, GABBR2 |
D00241 |
Baclofen |
[5] 2, 10, 13, 18, 149 |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00550 |
Midazolam |
[10] 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
D00696 |
D05028 |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
73 | Gap junction 15 genes, 7 drugs (DrugBank), 13 diseases shown |
[2] DRD1, DRD2 |
D09886 |
Dexpramipexole |
[1] 2 |
D00059 |
Levodopa |
[7] 2, 4, 6, 17, 90, 164, 201 |
[1] DRD2 |
D00560 |
Pimozide |
[1] 2 |
D00559 |
Pramipexole |
[2] 2, 6 |
D05575 |
[4] DRD2, HTR2A, HTR2B, HTR2C |
D00454 |
Olanzapine |
[2] 2, 8 |
D06623 |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 |
D00570 |
Colchicine |
[5] 2, 42, 56, 93, 266 |
74 | Gastric acid secretion 5 genes, 4 drugs (DrugBank), 3 diseases shown |
[2] ATP4A, ATP4B |
D00724 |
Rabeprazole |
[2] 2, 51 |
D08463 |
[1] CHRM3 |
D00138 |
Scopolamine |
[1] 2 |
[1] HRH2 |
D00295 |
Cimetidine |
[1] 2 |
D03503 |
[1] KCNQ1 |
D09569 |
Ezogabine |
[2] 2, 144 |
75 | Gastric cancer 2 genes, 2 drugs (DrugBank), 39 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] RARB |
D00094 |
Tretinoin |
[5] 2, 63, 75, 94, 231 |
76 | Glioma 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
77 | Glucagon signaling pathway 6 genes, 4 drugs (DrugBank), 32 diseases shown |
[1] PDE3B |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
D01453 |
D01385 |
Ibudilast |
[2] 2, 13 |
D04720 |
Levosimendan |
[1] 2 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
78 | Glutamatergic synapse 19 genes, 7 drugs (DrugBank), 43 diseases shown |
[4] GRIA1, GRIA2, GRIA3, GRIA4 |
D08964 |
Perampanel |
[3] 2, 6, 144 |
D02696 |
Talampanel |
[2] 2, 6 |
[14] GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
D07283 |
Esketamine |
[3] 2, 4, 70 |
D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
D08174 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
79 | Glycine, serine and threonine metabolism 1 gene, 1 drug (DrugBank), 4 diseases shown |
[1] MAOB |
D02562 |
Rasagiline |
[4] 2, 5, 6, 17 |
D08469 |
D10829 |
80 | GnRH secretion 6 genes, 3 drugs (DrugBank), 21 diseases shown |
[3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
[1] ESR2 |
D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
D08559 |
[2] GABBR1, GABBR2 |
D00241 |
Baclofen |
[5] 2, 10, 13, 18, 149 |
81 | GnRH signaling pathway 2 genes, 2 drugs (DrugBank), 6 diseases shown |
[1] GNRHR |
D00989 |
Leuprolide |
[5] 1, 2, 3, 51, 76 |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
82 | Graft-versus-host disease 21 genes, 2 drugs (DrugBank), 20 diseases shown |
[20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
83 | Growth hormone synthesis, secretion and action 2 genes, 2 drugs (DrugBank), 50 diseases shown |
[1] GHR |
D02691 |
Somatotropin |
[18] 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
84 | Hematopoietic cell lineage 22 genes, 10 drugs (DrugBank), 60 diseases shown |
[1] CSF3R |
D03235 |
Filgrastim |
[28] 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
D03247 |
Lenograstim |
[3] 2, 57, 65 |
[1] EPOR |
D03231 |
Erythropoietin |
[9] 2, 6, 13, 22, 46, 47, 70, 95, 96 |
[14] HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
[2] IL1R1, IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
[1] IL2RA |
D00748 |
Aldesleukin |
[4] 2, 49, 65, 97 |
D03058 |
Basiliximab |
[7] 2, 50, 65, 66, 97, 222, 228 |
[1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
[1] KIT |
D10229 |
Masitinib |
[6] 2, 5, 6, 13, 46, 96 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
85 | Hepatitis B 2 genes, 2 drugs (DrugBank), 19 diseases shown |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
86 | Hepatitis C 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
87 | Hepatocellular carcinoma 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
88 | Herpes simplex virus 1 infection 24 genes, 5 drugs (DrugBank), 49 diseases shown |
[20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] PML |
D00094 |
Tretinoin |
[5] 2, 63, 75, 94, 231 |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
89 | HIF-1 signaling pathway 2 genes, 2 drugs (DrugBank), 46 diseases shown |
[1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
90 | Histidine metabolism 1 gene, 1 drug (DrugBank), 4 diseases shown |
[1] MAOB |
D02562 |
Rasagiline |
[4] 2, 5, 6, 17 |
D08469 |
D10829 |
91 | Human cytomegalovirus infection 19 genes, 9 drugs (DrugBank), 72 diseases shown |
[6] HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
[1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
[1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] PTGS2 |
D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
[2] ROCK1, ROCK2 |
D07941 |
Fasudil |
[1] 2 |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
92 | Human immunodeficiency virus 1 infection 13 genes, 4 drugs (DrugBank), 58 diseases shown |
[6] HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
93 | Human papillomavirus infection 9 genes, 4 drugs (DrugBank), 50 diseases shown |
[6] HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] PTGS2 |
D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
94 | Human T-cell leukemia virus 1 infection 31 genes, 6 drugs (DrugBank), 49 diseases shown |
[20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
[2] IL1R1, IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
[1] IL2RA |
D03058 |
Basiliximab |
[7] 2, 50, 65, 66, 97, 222, 228 |
[3] IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
[4] 2, 49, 65, 97 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
95 | Huntington disease 3 genes, 5 drugs (DrugBank), 28 diseases shown |
[2] GRIN1, GRIN2B |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
D07283 |
Esketamine |
[3] 2, 4, 70 |
D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
D08174 |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
[1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
96 | Hypertrophic cardiomyopathy (HCM) 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
97 | IL-17 signaling pathway 2 genes, 2 drugs (DrugBank), 24 diseases shown |
[1] PTGS2 |
D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
98 | Inflammatory bowel disease (IBD) 16 genes, 3 drugs (DrugBank), 20 diseases shown |
[14] HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
[1] IL2RG |
D00748 |
Aldesleukin |
[4] 2, 49, 65, 97 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
99 | Inflammatory mediator regulation of TRP channels 7 genes, 4 drugs (DrugBank), 22 diseases shown |
[4] HRH1, HTR2A, HTR2B, HTR2C |
D00454 |
Olanzapine |
[2] 2, 8 |
D06623 |
[1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
[1] TRPV1 |
D00250 |
Capsaicin |
[6] 2, 6, 19, 86, 113, 226 |
100 | Influenza A 16 genes, 3 drugs (DrugBank), 23 diseases shown |
[14] HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
[1] PML |
D00094 |
Tretinoin |
[5] 2, 63, 75, 94, 231 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
101 | Insulin resistance 2 genes, 2 drugs (DrugBank), 46 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
102 | Insulin secretion 2 genes, 3 drugs (DrugBank), 13 diseases shown |
[1] CHRM3 |
D00138 |
Scopolamine |
[1] 2 |
[1] SNAP25 |
D02735 |
Botulinum Toxin Type B |
[3] 2, 6, 51 |
D00783 |
Botulinum toxin type A |
[13] 2, 5, 6, 7, 13, 15, 17, 36, 51, 70, 113, 149, 226 |
103 | Insulin signaling pathway 2 genes, 4 drugs (DrugBank), 39 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] PDE3B |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
D01453 |
D01385 |
Ibudilast |
[2] 2, 13 |
D04720 |
Levosimendan |
[1] 2 |
104 | Intestinal immune network for IgA production 14 genes, 1 drug (DrugBank), 4 diseases shown |
[14] HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
105 | JAK-STAT signaling pathway 8 genes, 8 drugs (DrugBank), 76 diseases shown |
[1] CSF3R |
D03235 |
Filgrastim |
[28] 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
D03247 |
Lenograstim |
[3] 2, 57, 65 |
[1] EPOR |
D03231 |
Erythropoietin |
[9] 2, 6, 13, 22, 46, 47, 70, 95, 96 |
[1] GHR |
D02691 |
Somatotropin |
[18] 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
[1] IL2RA |
D03058 |
Basiliximab |
[7] 2, 50, 65, 66, 97, 222, 228 |
[3] IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
[4] 2, 49, 65, 97 |
[1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
106 | Kaposi sarcoma-associated herpesvirus infection 14 genes, 5 drugs (DrugBank), 54 diseases shown |
[6] HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] PTGS2 |
D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
107 | Legionellosis 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
108 | Leishmaniasis 16 genes, 3 drugs (DrugBank), 26 diseases shown |
[14] HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
[1] PTGS2 |
D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
109 | Leukocyte transendothelial migration 2 genes, 1 drug (DrugBank), 1 disease shown |
[2] ROCK1, ROCK2 |
D07941 |
Fasudil |
[1] 2 |
110 | Long-term depression 3 genes, 3 drugs (DrugBank), 9 diseases shown |
[3] GRIA1, GRIA2, GRIA3 |
D08964 |
Perampanel |
[3] 2, 6, 144 |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
D02696 |
Talampanel |
[2] 2, 6 |
111 | Long-term potentiation 12 genes, 7 drugs (DrugBank), 43 diseases shown |
[2] GRIA1, GRIA2 |
D08964 |
Perampanel |
[3] 2, 6, 144 |
D02696 |
Talampanel |
[2] 2, 6 |
[7] GRIA1, GRIA2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
D07283 |
Esketamine |
[3] 2, 4, 70 |
D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
D08174 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
112 | Longevity regulating pathway 2 genes, 2 drugs (DrugBank), 44 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
113 | Longevity regulating pathway - multiple species 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
114 | Malaria 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
115 | MAPK signaling pathway 11 genes, 5 drugs (DrugBank), 59 diseases shown |
[3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
[1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
[1] KIT |
D10229 |
Masitinib |
[6] 2, 5, 6, 13, 46, 96 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
116 | Measles 3 genes, 2 drugs (DrugBank), 8 diseases shown |
[1] IL2RA |
D03058 |
Basiliximab |
[7] 2, 50, 65, 66, 97, 222, 228 |
[3] IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
[4] 2, 49, 65, 97 |
117 | Melanogenesis 1 gene, 1 drug (DrugBank), 6 diseases shown |
[1] KIT |
D10229 |
Masitinib |
[6] 2, 5, 6, 13, 46, 96 |
118 | Metabolic pathways 21 genes, 11 drugs (DrugBank), 55 diseases shown |
[4] ABAT, ALDH5A1, GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
[2] ATP4A, ATP4B |
D00724 |
Rabeprazole |
[2] 2, 51 |
D08463 |
[1] DDC |
D00558 |
Carbidopa |
[8] 2, 4, 6, 13, 17, 90, 164, 201 |
[2] IMPDH1, IMPDH2 |
D00752 |
Mycophenolate mofetil |
[32] 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
D05094 |
D05095 |
D05096 |
Mycophenolic acid |
[34] 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
[1] MAOB |
D02562 |
Rasagiline |
[4] 2, 5, 6, 17 |
D08469 |
D10829 |
[9] PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
D01453 |
[2] PDE3A, PDE3B |
D04720 |
Levosimendan |
[1] 2 |
[6] PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D |
D01385 |
Ibudilast |
[2] 2, 13 |
[1] PTGS2 |
D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
[1] XDH |
D01206 |
Febuxostat |
[3] 2, 6, 13 |
119 | MicroRNAs in cancer 4 genes, 4 drugs (DrugBank), 40 diseases shown |
[1] ABL1 |
D03252 |
Bosutinib |
[2] 2, 67 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] PTGS2 |
D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
[1] ROCK1 |
D07941 |
Fasudil |
[1] 2 |
120 | Mitophagy - animal 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
121 | Morphine addiction 28 genes, 7 drugs (DrugBank), 19 diseases shown |
[9] ADORA1, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
D01453 |
[1] DRD1 |
D09886 |
Dexpramipexole |
[1] 2 |
D00059 |
Levodopa |
[7] 2, 4, 6, 17, 90, 164, 201 |
[2] GABBR1, GABBR2 |
D00241 |
Baclofen |
[5] 2, 10, 13, 18, 149 |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00550 |
Midazolam |
[10] 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
D00696 |
D05028 |
[2] PDE3A, PDE3B |
D04720 |
Levosimendan |
[1] 2 |
[6] PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D |
D01385 |
Ibudilast |
[2] 2, 13 |
122 | mTOR signaling pathway 2 genes, 2 drugs (DrugBank), 46 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
123 | Natural killer cell mediated cytotoxicity 11 genes, 3 drugs (DrugBank), 41 diseases shown |
[5] HLA-A, HLA-B, HLA-C, HLA-E, HLA-G |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
124 | Necroptosis 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
125 | Neuroactive ligand-receptor interaction 66 genes, 29 drugs (DrugBank), 94 diseases shown |
[2] ADORA1, ADORA2A |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
D01453 |
[11] ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4, HRH1, HTR2A, HTR2B, HTR2C, HTR6 |
D00454 |
Olanzapine |
[2] 2, 8 |
D06623 |
[3] ADRA2A, ADRA2B, ADRA2C |
D00514 |
Dexmedetomidine |
[11] 2, 4, 6, 21, 34, 70, 113, 212, 215, 226, 280 |
D01205 |
D04375 |
Guanabenz |
[2] 2, 13 |
[5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 |
D00138 |
Scopolamine |
[1] 2 |
[2] CNR1, CNR2 |
D10915 |
Cannabidiol |
[14] 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
D00306 |
Dronabinol |
[5] 2, 13, 46, 271, 298 |
[2] CYSLTR1, PTGIR |
D01385 |
Ibudilast |
[2] 2, 13 |
[5] DRD1, DRD2, DRD3, DRD4, DRD5 |
D09886 |
Dexpramipexole |
[1] 2 |
D00059 |
Levodopa |
[7] 2, 4, 6, 17, 90, 164, 201 |
[2] DRD2, DRD3 |
D00560 |
Pimozide |
[1] 2 |
[3] DRD2, DRD3, DRD4 |
D00559 |
Pramipexole |
[2] 2, 6 |
D05575 |
[2] GABBR1, GABBR2 |
D00241 |
Baclofen |
[5] 2, 10, 13, 18, 149 |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00550 |
Midazolam |
[10] 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
D00696 |
D05028 |
[1] GHR |
D02691 |
Somatotropin |
[18] 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
[1] GNRHR |
D00989 |
Leuprolide |
[5] 1, 2, 3, 51, 76 |
[4] GRIA1, GRIA2, GRIA3, GRIA4 |
D08964 |
Perampanel |
[3] 2, 6, 144 |
D02696 |
Talampanel |
[2] 2, 6 |
[14] GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
D07283 |
Esketamine |
[3] 2, 4, 70 |
D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
D08174 |
[1] HRH2 |
D00295 |
Cimetidine |
[1] 2 |
D03503 |
[1] MC2R |
D00146 |
Corticotropin |
[12] 2, 13, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 |
[1] NR3C1 |
D00244 |
Betamethasone |
[6] 2, 46, 65, 90, 96, 235 |
D00972 |
D01357 |
D01402 |
D01637 |
D02032 |
D02286 |
D00407 |
Methylprednisolone |
[36] 2, 13, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 145, 164, 220, 222, 224, 271, 283, 284, 285, 296 |
D00751 |
D00979 |
D05000 |
D05001 |
D05002 |
D00473 |
Prednisone |
[44] 2, 11, 13, 14, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 95, 96, 97, 113, 145, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
[1] S1PR1 |
D10001 |
Fingolimod |
[4] 2, 13, 14, 156 |
[1] TRPV1 |
D00250 |
Capsaicin |
[6] 2, 6, 19, 86, 113, 226 |
126 | Neurotrophin signaling pathway 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] ABL1 |
D03252 |
Bosutinib |
[2] 2, 67 |
127 | NF-kappa B signaling pathway 3 genes, 3 drugs (DrugBank), 36 diseases shown |
[1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
[1] PTGS2 |
D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
128 | Nicotine addiction 25 genes, 7 drugs (DrugBank), 21 diseases shown |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00550 |
Midazolam |
[10] 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
D00696 |
D05028 |
[4] GRIA1, GRIA2, GRIA3, GRIA4 |
D08964 |
Perampanel |
[3] 2, 6, 144 |
D02696 |
Talampanel |
[2] 2, 6 |
[9] GRIA1, GRIA2, GRIA3, GRIA4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
D07283 |
Esketamine |
[3] 2, 4, 70 |
D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
D08174 |
129 | NOD-like receptor signaling pathway 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
130 | Non-alcoholic fatty liver disease (NAFLD) 2 genes, 2 drugs (DrugBank), 29 diseases shown |
[1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
131 | Non-small cell lung cancer 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] RARB |
D00094 |
Tretinoin |
[5] 2, 63, 75, 94, 231 |
132 | Olfactory transduction 2 genes, 1 drug (DrugBank), 6 diseases shown |
[2] PDE1B, PDE2A |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
D01453 |
133 | Oocyte meiosis 6 genes, 2 drugs (DrugBank), 34 diseases shown |
[1] AR |
D00075 |
Testosterone |
[7] 1, 2, 3, 13, 78, 113, 265 |
D00957 |
D00958 |
D00959 |
D06085 |
D06087 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
134 | Osteoclast differentiation 8 genes, 4 drugs (DrugBank), 54 diseases shown |
[1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
[1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
135 | Ovarian steroidogenesis 1 gene, 1 drug (DrugBank), 9 diseases shown |
[1] PTGS2 |
D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
136 | Oxidative phosphorylation 2 genes, 1 drug (DrugBank), 2 diseases shown |
[2] ATP4A, ATP4B |
D00724 |
Rabeprazole |
[2] 2, 51 |
D08463 |
137 | Oxytocin signaling pathway 9 genes, 4 drugs (DrugBank), 37 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] PTGS2 |
D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
[2] ROCK1, ROCK2 |
D07941 |
Fasudil |
[1] 2 |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
138 | Pancreatic cancer 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
139 | Pancreatic secretion 2 genes, 2 drugs (DrugBank), 2 diseases shown |
[1] CHRM3 |
D00138 |
Scopolamine |
[1] 2 |
[1] KCNQ1 |
D09569 |
Ezogabine |
[2] 2, 144 |
140 | Parathyroid hormone synthesis, secretion and action 4 genes, 2 drugs (DrugBank), 7 diseases shown |
[4] PDE4A, PDE4B, PDE4C, PDE4D |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
D01453 |
D01385 |
Ibudilast |
[2] 2, 13 |
141 | Parkinson disease 3 genes, 6 drugs (DrugBank), 12 diseases shown |
[1] ADORA2A |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
D01453 |
[2] DRD1, DRD2 |
D09886 |
Dexpramipexole |
[1] 2 |
D00059 |
Levodopa |
[7] 2, 4, 6, 17, 90, 164, 201 |
[1] DRD2 |
D00454 |
Olanzapine |
[2] 2, 8 |
D06623 |
D00560 |
Pimozide |
[1] 2 |
D00559 |
Pramipexole |
[2] 2, 6 |
D05575 |
142 | Pathogenic Escherichia coli infection 14 genes, 5 drugs (DrugBank), 34 diseases shown |
[1] ABL1 |
D03252 |
Bosutinib |
[2] 2, 67 |
[1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
[2] ROCK1, ROCK2 |
D07941 |
Fasudil |
[1] 2 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 |
D00570 |
Colchicine |
[5] 2, 42, 56, 93, 266 |
143 | Pathways in cancer 19 genes, 15 drugs (DrugBank), 78 diseases shown |
[1] ABL1 |
D03252 |
Bosutinib |
[2] 2, 67 |
[1] AR |
D00075 |
Testosterone |
[7] 1, 2, 3, 13, 78, 113, 265 |
D00957 |
D00958 |
D00959 |
D06085 |
D06087 |
[1] CSF3R |
D03235 |
Filgrastim |
[28] 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
D03247 |
Lenograstim |
[3] 2, 57, 65 |
[1] EPOR |
D03231 |
Erythropoietin |
[9] 2, 6, 13, 22, 46, 47, 70, 95, 96 |
[2] ESR1, ESR2 |
D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
D08559 |
[1] IL2RA |
D03058 |
Basiliximab |
[7] 2, 50, 65, 66, 97, 222, 228 |
[3] IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
[4] 2, 49, 65, 97 |
[1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
[1] KIT |
D10229 |
Masitinib |
[6] 2, 5, 6, 13, 46, 96 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[3] PML, RARA, RARB |
D00094 |
Tretinoin |
[5] 2, 63, 75, 94, 231 |
[1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
[1] PTGS2 |
D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
[2] ROCK1, ROCK2 |
D07941 |
Fasudil |
[1] 2 |
144 | PD-L1 expression and PD-1 checkpoint pathway in cancer 6 genes, 2 drugs (DrugBank), 49 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
145 | Peroxisome 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] XDH |
D01206 |
Febuxostat |
[3] 2, 6, 13 |
146 | Pertussis 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
147 | Phagosome 29 genes, 2 drugs (DrugBank), 8 diseases shown |
[20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 |
D00570 |
Colchicine |
[5] 2, 42, 56, 93, 266 |
148 | Phenylalanine metabolism 2 genes, 2 drugs (DrugBank), 9 diseases shown |
[1] DDC |
D00558 |
Carbidopa |
[8] 2, 4, 6, 13, 17, 90, 164, 201 |
[1] MAOB |
D02562 |
Rasagiline |
[4] 2, 5, 6, 17 |
D08469 |
D10829 |
149 | Phospholipase D signaling pathway 2 genes, 2 drugs (DrugBank), 38 diseases shown |
[1] KIT |
D10229 |
Masitinib |
[6] 2, 5, 6, 13, 46, 96 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
150 | PI3K-Akt signaling pathway 11 genes, 10 drugs (DrugBank), 77 diseases shown |
[2] CHRM1, CHRM2 |
D00138 |
Scopolamine |
[1] 2 |
[1] CSF3R |
D03235 |
Filgrastim |
[28] 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
D03247 |
Lenograstim |
[3] 2, 57, 65 |
[1] EPOR |
D03231 |
Erythropoietin |
[9] 2, 6, 13, 22, 46, 47, 70, 95, 96 |
[1] GHR |
D02691 |
Somatotropin |
[18] 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
[1] IL2RA |
D03058 |
Basiliximab |
[7] 2, 50, 65, 66, 97, 222, 228 |
[3] IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
[4] 2, 49, 65, 97 |
[1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
[1] KIT |
D10229 |
Masitinib |
[6] 2, 5, 6, 13, 46, 96 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
151 | Platelet activation 4 genes, 3 drugs (DrugBank), 3 diseases shown |
[1] PTGIR |
D01385 |
Ibudilast |
[2] 2, 13 |
[2] ROCK1, ROCK2 |
D07941 |
Fasudil |
[1] 2 |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
152 | PPAR signaling pathway 1 gene, 1 drug (DrugBank), 17 diseases shown |
[1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
153 | Primary immunodeficiency 1 gene, 1 drug (DrugBank), 4 diseases shown |
[1] IL2RG |
D00748 |
Aldesleukin |
[4] 2, 49, 65, 97 |
154 | Progesterone-mediated oocyte maturation 1 gene, 3 drugs (DrugBank), 7 diseases shown |
[1] PDE3B |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
D01453 |
D01385 |
Ibudilast |
[2] 2, 13 |
D04720 |
Levosimendan |
[1] 2 |
155 | Prolactin signaling pathway 3 genes, 2 drugs (DrugBank), 5 diseases shown |
[2] ESR1, ESR2 |
D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
D08559 |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
156 | Propanoate metabolism 1 gene, 1 drug (DrugBank), 14 diseases shown |
[1] ABAT |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
157 | Prostate cancer 3 genes, 3 drugs (DrugBank), 51 diseases shown |
[1] AR |
D00075 |
Testosterone |
[7] 1, 2, 3, 13, 78, 113, 265 |
D00957 |
D00958 |
D00959 |
D06085 |
D06087 |
[1] IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
158 | Protein digestion and absorption 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] KCNQ1 |
D09569 |
Ezogabine |
[2] 2, 144 |
159 | Proteoglycans in cancer 6 genes, 5 drugs (DrugBank), 47 diseases shown |
[1] ESR1 |
D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
D08559 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[2] ROCK1, ROCK2 |
D07941 |
Fasudil |
[1] 2 |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
160 | Purine metabolism 12 genes, 6 drugs (DrugBank), 38 diseases shown |
[2] IMPDH1, IMPDH2 |
D00752 |
Mycophenolate mofetil |
[32] 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
D05094 |
D05095 |
D05096 |
Mycophenolic acid |
[34] 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
[9] PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
D01453 |
[2] PDE3A, PDE3B |
D04720 |
Levosimendan |
[1] 2 |
[6] PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D |
D01385 |
Ibudilast |
[2] 2, 13 |
[1] XDH |
D01206 |
Febuxostat |
[3] 2, 6, 13 |
161 | Rap1 signaling pathway 8 genes, 14 drugs (DrugBank), 31 diseases shown |
[1] ADORA2A |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
D01453 |
[1] CNR1 |
D10915 |
Cannabidiol |
[14] 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
D00306 |
Dronabinol |
[5] 2, 13, 46, 271, 298 |
[1] DRD2 |
D09886 |
Dexpramipexole |
[1] 2 |
D00059 |
Levodopa |
[7] 2, 4, 6, 17, 90, 164, 201 |
D00454 |
Olanzapine |
[2] 2, 8 |
D06623 |
D00560 |
Pimozide |
[1] 2 |
D00559 |
Pramipexole |
[2] 2, 6 |
D05575 |
[3] GRIN1, GRIN2A, GRIN2B |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
D07283 |
Esketamine |
[3] 2, 4, 70 |
D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
D08174 |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
[1] KIT |
D10229 |
Masitinib |
[6] 2, 5, 6, 13, 46, 96 |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
162 | Ras signaling pathway 5 genes, 6 drugs (DrugBank), 19 diseases shown |
[1] ABL1 |
D03252 |
Bosutinib |
[2] 2, 67 |
[3] GRIN1, GRIN2A, GRIN2B |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
D07283 |
Esketamine |
[3] 2, 4, 70 |
D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
D08174 |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
[1] KIT |
D10229 |
Masitinib |
[6] 2, 5, 6, 13, 46, 96 |
163 | Regulation of actin cytoskeleton 8 genes, 3 drugs (DrugBank), 2 diseases shown |
[5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 |
D00138 |
Scopolamine |
[1] 2 |
[2] ROCK1, ROCK2 |
D07941 |
Fasudil |
[1] 2 |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
164 | Regulation of lipolysis in adipocytes 3 genes, 4 drugs (DrugBank), 13 diseases shown |
[2] ADORA1, PDE3B |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
D01453 |
[1] PDE3B |
D01385 |
Ibudilast |
[2] 2, 13 |
D04720 |
Levosimendan |
[1] 2 |
[1] PTGS2 |
D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
165 | Relaxin signaling pathway 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
166 | Renin secretion 9 genes, 4 drugs (DrugBank), 32 diseases shown |
[4] ADORA1, PDE1B, PDE3A, PDE3B |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
D01453 |
[2] PDE3A, PDE3B |
D01385 |
Ibudilast |
[2] 2, 13 |
D04720 |
Levosimendan |
[1] 2 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
167 | Retrograde endocannabinoid signaling 22 genes, 7 drugs (DrugBank), 25 diseases shown |
[1] CNR1 |
D10915 |
Cannabidiol |
[14] 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
D00306 |
Dronabinol |
[5] 2, 13, 46, 271, 298 |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00550 |
Midazolam |
[10] 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
D00696 |
D05028 |
[4] GRIA1, GRIA2, GRIA3, GRIA4 |
D08964 |
Perampanel |
[3] 2, 6, 144 |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
D02696 |
Talampanel |
[2] 2, 6 |
[1] PTGS2 |
D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
168 | Rheumatoid arthritis 15 genes, 2 drugs (DrugBank), 20 diseases shown |
[14] HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
169 | RIG-I-like receptor signaling pathway 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
170 | Salivary secretion 4 genes, 2 drugs (DrugBank), 2 diseases shown |
[3] ADRA1A, ADRA1B, ADRA1D |
D00454 |
Olanzapine |
[2] 2, 8 |
D06623 |
[1] CHRM3 |
D00138 |
Scopolamine |
[1] 2 |
171 | Salmonella infection 2 genes, 1 drug (DrugBank), 1 disease shown |
[2] ROCK1, ROCK2 |
D07941 |
Fasudil |
[1] 2 |
172 | Serotonergic synapse 11 genes, 6 drugs (DrugBank), 21 diseases shown |
[1] DDC |
D00558 |
Carbidopa |
[8] 2, 4, 6, 13, 17, 90, 164, 201 |
[3] GABRB1, GABRB2, GABRB3 |
D00550 |
Midazolam |
[10] 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
D00696 |
D05028 |
[4] HTR2A, HTR2B, HTR2C, HTR6 |
D00454 |
Olanzapine |
[2] 2, 8 |
D06623 |
[1] MAOB |
D02562 |
Rasagiline |
[4] 2, 5, 6, 17 |
D08469 |
D10829 |
[1] PTGS2 |
D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
[1] SLC6A4 |
D02567 |
Escitalopram |
[3] 2, 6, 13 |
D07704 |
D07913 |
173 | Shigellosis 7 genes, 5 drugs (DrugBank), 55 diseases shown |
[2] ABL1, SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
[1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[2] ROCK1, ROCK2 |
D07941 |
Fasudil |
[1] 2 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
174 | Small cell lung cancer 2 genes, 2 drugs (DrugBank), 13 diseases shown |
[1] PTGS2 |
D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
[1] RARB |
D00094 |
Tretinoin |
[5] 2, 63, 75, 94, 231 |
175 | Sphingolipid signaling pathway 5 genes, 4 drugs (DrugBank), 24 diseases shown |
[1] ADORA1 |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
D01453 |
[2] ROCK1, ROCK2 |
D07941 |
Fasudil |
[1] 2 |
[1] S1PR1 |
D10001 |
Fingolimod |
[4] 2, 13, 14, 156 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
176 | Staphylococcus aureus infection 14 genes, 1 drug (DrugBank), 4 diseases shown |
[14] HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
177 | Synaptic vesicle cycle 2 genes, 3 drugs (DrugBank), 13 diseases shown |
[1] SLC6A4 |
D02567 |
Escitalopram |
[3] 2, 6, 13 |
D07704 |
D07913 |
[1] SNAP25 |
D02735 |
Botulinum Toxin Type B |
[3] 2, 6, 51 |
D00783 |
Botulinum toxin type A |
[13] 2, 5, 6, 7, 13, 15, 17, 36, 51, 70, 113, 149, 226 |
178 | Systemic lupus erythematosus 17 genes, 6 drugs (DrugBank), 32 diseases shown |
[2] GRIN2A, GRIN2B |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
D03742 |
D03744 |
D07283 |
Esketamine |
[3] 2, 4, 70 |
D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
D08174 |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
[14] HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
179 | T cell receptor signaling pathway 6 genes, 2 drugs (DrugBank), 40 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
180 | Taste transduction 13 genes, 7 drugs (DrugBank), 18 diseases shown |
[1] CHRM3 |
D00138 |
Scopolamine |
[1] 2 |
[2] GABBR1, GABBR2 |
D00241 |
Baclofen |
[5] 2, 10, 13, 18, 149 |
[6] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 |
D00550 |
Midazolam |
[10] 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
D00696 |
D05028 |
[1] PDE1B |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
D01453 |
[3] SCN2A, SCN3A, SCN9A |
D00639 |
Mexiletine |
[5] 1, 2, 10, 113, 114 |
D08215 |
D00642 |
Quinidine |
[3] 2, 8, 13 |
D00643 |
D02272 |
D08458 |
[2] SCN3A, SCN9A |
D07299 |
Lacosamide |
[3] 2, 46, 149 |
181 | Taurine and hypotaurine metabolism 2 genes, 1 drug (DrugBank), 14 diseases shown |
[2] GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
182 | TGF-beta signaling pathway 2 genes, 2 drugs (DrugBank), 18 diseases shown |
[1] ROCK1 |
D07941 |
Fasudil |
[1] 2 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
183 | Th1 and Th2 cell differentiation 22 genes, 4 drugs (DrugBank), 31 diseases shown |
[14] HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
[1] IL2RA |
D03058 |
Basiliximab |
[7] 2, 50, 65, 66, 97, 222, 228 |
[3] IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
[4] 2, 49, 65, 97 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
184 | Th17 cell differentiation 26 genes, 8 drugs (DrugBank), 66 diseases shown |
[14] HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
[1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
[1] IL2RA |
D03058 |
Basiliximab |
[7] 2, 50, 65, 66, 97, 222, 228 |
[3] IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
[4] 2, 49, 65, 97 |
[1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] RARA |
D00094 |
Tretinoin |
[5] 2, 63, 75, 94, 231 |
185 | Thermogenesis 3 genes, 4 drugs (DrugBank), 51 diseases shown |
[1] CNR1 |
D10915 |
Cannabidiol |
[14] 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
D00306 |
Dronabinol |
[5] 2, 13, 46, 271, 298 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
186 | Thyroid cancer 1 gene, 1 drug (DrugBank), 17 diseases shown |
[1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
187 | Thyroid hormone signaling pathway 3 genes, 3 drugs (DrugBank), 38 diseases shown |
[1] ESR1 |
D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
D08559 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
188 | Tight junction 3 genes, 2 drugs (DrugBank), 2 diseases shown |
[2] ROCK1, ROCK2 |
D07941 |
Fasudil |
[1] 2 |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
189 | TNF signaling pathway 2 genes, 2 drugs (DrugBank), 24 diseases shown |
[1] PTGS2 |
D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
190 | Toll-like receptor signaling pathway 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
191 | Toxoplasmosis 15 genes, 2 drugs (DrugBank), 20 diseases shown |
[14] HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
192 | Transcriptional misregulation in cancer 6 genes, 7 drugs (DrugBank), 37 diseases shown |
[1] GRIA3 |
D08964 |
Perampanel |
[3] 2, 6, 144 |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
D02696 |
Talampanel |
[2] 2, 6 |
[1] IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
[1] IL2RB |
D00748 |
Aldesleukin |
[4] 2, 49, 65, 97 |
[2] PML, RARA |
D00094 |
Tretinoin |
[5] 2, 63, 75, 94, 231 |
[1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
193 | Tryptophan metabolism 2 genes, 2 drugs (DrugBank), 9 diseases shown |
[1] DDC |
D00558 |
Carbidopa |
[8] 2, 4, 6, 13, 17, 90, 164, 201 |
[1] MAOB |
D02562 |
Rasagiline |
[4] 2, 5, 6, 17 |
D08469 |
D10829 |
194 | Tuberculosis 21 genes, 4 drugs (DrugBank), 42 diseases shown |
[14] HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
195 | Type I diabetes mellitus 23 genes, 3 drugs (DrugBank), 31 diseases shown |
[2] GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
[20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
196 | Type II diabetes mellitus 3 genes, 3 drugs (DrugBank), 53 diseases shown |
[1] CACNA1G |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
197 | Tyrosine metabolism 2 genes, 2 drugs (DrugBank), 9 diseases shown |
[1] DDC |
D00558 |
Carbidopa |
[8] 2, 4, 6, 13, 17, 90, 164, 201 |
[1] MAOB |
D02562 |
Rasagiline |
[4] 2, 5, 6, 17 |
D08469 |
D10829 |
198 | Ubiquitin mediated proteolysis 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] PML |
D00094 |
Tretinoin |
[5] 2, 63, 75, 94, 231 |
199 | Valine, leucine and isoleucine degradation 1 gene, 1 drug (DrugBank), 14 diseases shown |
[1] ABAT |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
200 | Vascular smooth muscle contraction 7 genes, 4 drugs (DrugBank), 8 diseases shown |
[1] ADORA2A |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
D01453 |
[3] ADRA1A, ADRA1B, ADRA1D |
D00454 |
Olanzapine |
[2] 2, 8 |
D06623 |
[1] PTGIR |
D01385 |
Ibudilast |
[2] 2, 13 |
[2] ROCK1, ROCK2 |
D07941 |
Fasudil |
[1] 2 |
201 | VEGF signaling pathway 7 genes, 3 drugs (DrugBank), 37 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] PTGS2 |
D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
202 | Vibrio cholerae infection 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] KCNQ1 |
D09569 |
Ezogabine |
[2] 2, 144 |
203 | Viral carcinogenesis 7 genes, 2 drugs (DrugBank), 5 diseases shown |
[6] HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
204 | Viral myocarditis 21 genes, 2 drugs (DrugBank), 5 diseases shown |
[1] ABL1 |
D03252 |
Bosutinib |
[2] 2, 67 |
[20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
[4] 2, 13, 96, 156 |
205 | Viral protein interaction with cytokine and cytokine receptor 5 genes, 4 drugs (DrugBank), 32 diseases shown |
[1] IL2RA |
D03058 |
Basiliximab |
[7] 2, 50, 65, 66, 97, 222, 228 |
[3] IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
[4] 2, 49, 65, 97 |
[1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
206 | Wnt signaling pathway 6 genes, 2 drugs (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
[1] ROCK2 |
D07941 |
Fasudil |
[1] 2 |
207 | Yersinia infection 4 genes, 3 drugs (DrugBank), 19 diseases shown |
[2] ROCK1, ROCK2 |
D07941 |
Fasudil |
[1] 2 |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
[1] TNF |
D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |